跳至主要内容
临床试验/NCT05204459
NCT05204459招募中不适用

Investigating the Longitudinal Relationships Between Visual Pathway Injury, Radiological and Blood Biomarkers in Multiple Sclerosis and Related Disorders

Cedars-Sinai Medical Center1 个研究点 分布在 1 个国家目标入组 1,000 人开始时间: 2021年11月11日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
1,000
试验地点
1
主要终点
Identifying risk factors for disability progression

研究概览

简要总结

This study is being conducted to investigate risk factors for disability progression in Multiple Sclerosis and related disorders (MSRD). The primary goal is to assess whether combining information from visual assessment, blood markers, as well as historical and ongoing longitudinal MRIs of the brain, orbit (the part of the skull where eyes are located), and/or spinal cord can predict changes in quantitative disability measures related to MSRD and neurological disease.

详细描述

Screening:

Prospective participants will be screened at Cedars-Sinai Medical Center (CSMC) through a comprehensive review of their medical and MRI records done as part of standard of care to determine if they are eligible to participate in this study. If they never had an MRI at CSMC, they will be asked to provide records of an MRI done at another site. If the study team determines that they are eligible to continue participating, then they will move on to the main research study.

Main Research Study:

The following items will be collected as part of the main research study:

  • Demographic data and medical history, including medications, family, and social history
  • Complete a series of quantitative disability assessments,
  • Collection of historic MRI data obtained as part of standard of care

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects who meet any one of the following diagnostic criteria:
  • Diagnosis of MS, CIS,or RIS based on the 2017 revised McDonald criteria.
  • Diagnosis of NMOSD based on the 2015 revised NMOSD consensus diagnostic criteria.
  • Diagnosis of myelin oligodendrocyte glycoprotein (MOG)-related encephalomyelitis, optic neuritis, or other associated disease.
  • Diagnosis of neurological disorders other than MSRD.
  • Healthy volunteer.
  • Able to give informed consent.

排除标准

  • Patients will be excluded from the MRI portions of the study if they have a contraindication to MRI(metallic implantsor foreign bodies, claustrophobia, MRI-incompatible pacemakers, MRI- incompatible prosthetic heart valves).
  • Patients will be excluded from the MRI portions of the study if they are pregnant, but their demographic, clinical information,and disability measures may still be captured under the study.
  • Patients will be excluded from the visual assessment portions of the study if they have had any recent ocular surgery (within the past two months), refractive errors of greater than or equal to ±6 diopters or other eye diseases that may affect or confound OCT/OCTA measurements (ex., age-related macular degeneration, advanced geographic atrophy, diabetic retinopathy, glaucoma).

结局指标

主要结局

Identifying risk factors for disability progression

时间窗: 10 years

To investigate whether combining information from peripheral blood biomarkers, retinal structural, visual function, as well as historical and ongoing longitudinal MRIs (brain, cervical, and/or thoracic spinal cord) can predict quantitative disability progression risk

次要结局

  • Identify factors associated with visual disability and optic neuropathy in multiple sclerosis and related disorders(10 years)
  • Identify serum, genetic, and stem cell-derived biomarkers influencing disability risks(10 years)
  • Effect of disease modifying therapy(10 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Omar Al-Louzi

Staff Physician; Director, Visual Outcomes Lab

Cedars-Sinai Medical Center

研究点 (1)

Loading locations...

相似试验